Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the combination of itm8 and its current portfolio company AddPro
Mandate

Vinge advises Axcel in connection with the combination of itm8 and its current portfolio company AddPro

May 30, 2022 M&A

Axcel, in partnership with Chr. Augustinus Fabrikker, has agreed to acquire the Danish digital transformation partner, itm8, to create a northern European group within end-to-end IT services through a combination with Axcel-owned AddPro.

Over the years, itm8 and AddPro have individually built strong brands and the aim is to jointly expand the offering of IT-services in the northern European area. Vinge assisted Axcel as lead legal advisor in regard to the divestment of AddPro and Swedish law aspects of the combination with itm8.

The transaction is subject to customary regulatory approvals and is expected to close in Q3 2022.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Viktor Lennartsson and Nina Fathjalali (M&A), and Viktoria Owetz Leyva, Sara Dahlros Sköld, Christoffer Widström, Julia Hagelberg and Klara Lundquist (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025